← Open Payments lookup

KATHARINE VOGELAAR: Open Payments

NPI 1285144634 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$367 in 15 payments from 9 companies in 2025. Trend: 2023 $42 · 2024 $301 · 2025 $367

Food & beverage: $367
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$73
GENZYME CORPORATION2$51
GlaxoSmithKline, LLC.2$47
PFIZER INC.2$44
Ionis Pharmaceuticals, Inc.1$36
AstraZeneca Pharmaceuticals LP2$35
CSL Behring1$34
Takeda Pharmaceuticals U.S.A., Inc.1$28
Blueprint Medicines Corporation1$20

Products named: AYVAKIT, NUCALA, DAWNZERA, Hizentra, OCTAGAM IMMUNE GLOBULIN (HUMAN), CUVITRU, XOLAIR, Rhapsido.

Industry payments across TX — which companies pay providers there.